AlzeCure has been nominated as finalist for the 2025 European Lifestars Awards in the category Post IPO Raise of The Year.
The AlzeCure issue that has lead to the nomination as finalists was oversubscribed by 212% and done in July 2025.
The parties behind the successful issue are Zonda Partner, Corpura Fondkommession, Synch Law & Nordic Issuing.
The prize event will be held in London the 17th of November.